Fig. 5From: Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysisStratified analyses for the meta-analysis of the association between statin use and HCC risk in patients with HBV or HCV infection; a stratified analyses according to the properties of statins (lipophilic or hydrophilic); and b stratified analyses according to the accumulative dosages of statinsBack to article page